Drug Shortage Report for MINT-RISPERIDON

Last updated on 2020-09-21 History
Report ID 122516
Drug Identification Number 02359847
Brand name MINT-RISPERIDON
Common or Proper name Risperidon
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) RISPERIDONE
Strength(s) 4.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 count bottles
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-08-19
Estimated end date 2020-09-18
Actual end date 2020-09-18
Shortage status Resolved
Updated date 2020-09-21
Company comments In Transit delay due to strike.
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-09-21 French Compare
v4 2020-09-21 English Compare
v3 2020-08-20 English Compare
v2 2020-08-19 French Compare
v1 2020-08-19 English Compare

Showing 1 to 5 of 5